1. Home
  2. TECH vs PSN Comparison

TECH vs PSN Comparison

Compare TECH & PSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • PSN
  • Stock Information
  • Founded
  • TECH 1976
  • PSN 1944
  • Country
  • TECH United States
  • PSN United States
  • Employees
  • TECH N/A
  • PSN N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • PSN EDP Services
  • Sector
  • TECH Health Care
  • PSN Technology
  • Exchange
  • TECH Nasdaq
  • PSN Nasdaq
  • Market Cap
  • TECH 7.8B
  • PSN 6.8B
  • IPO Year
  • TECH 1989
  • PSN 2019
  • Fundamental
  • Price
  • TECH $46.78
  • PSN $66.16
  • Analyst Decision
  • TECH Buy
  • PSN Buy
  • Analyst Count
  • TECH 10
  • PSN 11
  • Target Price
  • TECH $73.44
  • PSN $87.44
  • AVG Volume (30 Days)
  • TECH 2.3M
  • PSN 1.6M
  • Earning Date
  • TECH 05-07-2025
  • PSN 04-30-2025
  • Dividend Yield
  • TECH 0.68%
  • PSN N/A
  • EPS Growth
  • TECH N/A
  • PSN 50.29
  • EPS
  • TECH 0.83
  • PSN 2.35
  • Revenue
  • TECH $1,208,770,000.00
  • PSN $6,769,260,000.00
  • Revenue This Year
  • TECH $7.16
  • PSN $5.09
  • Revenue Next Year
  • TECH $6.36
  • PSN $4.47
  • P/E Ratio
  • TECH $56.36
  • PSN $28.15
  • Revenue Growth
  • TECH 4.72
  • PSN 16.61
  • 52 Week Low
  • TECH $46.01
  • PSN $54.56
  • 52 Week High
  • TECH $83.96
  • PSN $114.68
  • Technical
  • Relative Strength Index (RSI)
  • TECH 39.97
  • PSN 51.78
  • Support Level
  • TECH $46.05
  • PSN $66.51
  • Resistance Level
  • TECH $49.92
  • PSN $68.53
  • Average True Range (ATR)
  • TECH 2.20
  • PSN 1.78
  • MACD
  • TECH -0.04
  • PSN 0.08
  • Stochastic Oscillator
  • TECH 8.74
  • PSN 60.58

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.

Share on Social Networks: